Early Tapering of Immunosuppressive Agents to Immunomodulation to Improve Survival of AML Patients
Status:
Unknown status
Trial end date:
2021-01-01
Target enrollment:
Participant gender:
Summary
Early reduction of immunosuppressive agents after HLA matched donor transplantation can
improve the survival of advanced stage acute myeloid leukemia.
single-center, open clinical study
Phase:
Phase 4
Details
Lead Sponsor:
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine